{"id":1229,"date":"2023-10-04T19:33:46","date_gmt":"2023-10-04T10:33:46","guid":{"rendered":"https:\/\/firm.or.jp\/en\/?post_type=venture-map&#038;p=1229"},"modified":"2025-09-29T19:09:30","modified_gmt":"2025-09-29T10:09:30","slug":"musculoskeletalclinical-trial-phase-iii","status":"publish","type":"venture-map","link":"https:\/\/firm.or.jp\/en\/venture-map\/musculoskeletalclinical-trial-phase-iii","title":{"rendered":"Musculoskeletal<br>Clinical Trial (Phase III)"},"content":{"rendered":"<div class=\"p-venture-map\">\n<div class=\"p-venture-map__single\">\n        <!-- \n\n<div class=\"p-venture-map__single__classification\">\n            \n\n<h2 class=\"p-venture-map__single__ttl\"><i>\u25a0<\/i> Classification<\/h2>\n\n\n            \n\n<figure>\n                <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/firm.or.jp\/en\/wp-content\/uploads\/sites\/5\/2023\/09\/venture-map_sample.png\" alt=\"\" width=\"366\" height=\"295\" class=\"alignnone size-full wp-image-1194\" srcset=\"https:\/\/firm.or.jp\/en\/wp-content\/uploads\/sites\/5\/2023\/09\/venture-map_sample.png 366w, https:\/\/firm.or.jp\/en\/wp-content\/uploads\/sites\/5\/2023\/09\/venture-map_sample-300x242.png 300w\" sizes=\"auto, (max-width: 366px) 100vw, 366px\" \/>\n            <\/figure>\n\n\n        <\/div>\n\n --><\/p>\n<div class=\"p-venture-map__single__download\">\n<h2 class=\"p-venture-map__single__ttl\"><i>\u25a0<\/i> PDF Download<\/h2>\n<p>            <!-- \n\n<p>Symptomatic knee cartilage defects and osteochondritis dissecans [1]<\/p>\n\n --><\/p>\n<ul>\n                <!-- \u25bc PDF \u25bc --><\/p>\n<li><a href=\"https:\/\/firm.or.jp\/en\/wp-content\/uploads\/sites\/5\/2025\/09\/A-0002\u3010CellSeed-Inc.\u3011Infosheet_2025.pdf\">Allogeneic Chondrocyte Cell Sheet for Knee Osteoarthritis Treatment\u3000\/\u3000CellSeed Inc.<\/a><\/li>\n<li><a href=\"https:\/\/firm.or.jp\/en\/wp-content\/uploads\/sites\/5\/2025\/09\/A-0013\u3010TWOCELLS-COMPANY-LIMITED\u3011Infosheet_2025.pdf\">gMSC\uff08guaranteed Mesenchymal Stem Cell\uff09\u24c71 for symptomatic knee cartilage defects and osteochondritis dissecans\u3000\/\u3000TWOCELLS COMPANY, LIMITED<\/a><\/li>\n<li><a href=\"https:\/\/firm.or.jp\/en\/wp-content\/uploads\/sites\/5\/2025\/09\/A-0024\u3010CynosBio-Inc.\u3011Infosheet_2025.pdf\">IK-01 (an autologous chondrocyte-based therapy designed to regenerate hyaline cartilage in the knee)\u3000\/\u3000CynosBio, Inc.<\/a><\/li>\n<p>                <!-- \u25b2 PDF \u25b2 -->\n            <\/ul>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n","protected":false},"author":1,"featured_media":0,"menu_order":0,"template":"","format":"standard","meta":{"_acf_changed":false},"class_list":["post-1229","venture-map","type-venture-map","status-publish","format-standard","hentry"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/firm.or.jp\/en\/wp-json\/wp\/v2\/venture-map\/1229","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/firm.or.jp\/en\/wp-json\/wp\/v2\/venture-map"}],"about":[{"href":"https:\/\/firm.or.jp\/en\/wp-json\/wp\/v2\/types\/venture-map"}],"author":[{"embeddable":true,"href":"https:\/\/firm.or.jp\/en\/wp-json\/wp\/v2\/users\/1"}],"wp:attachment":[{"href":"https:\/\/firm.or.jp\/en\/wp-json\/wp\/v2\/media?parent=1229"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}